HomeExpert Team Expert Team

Expert Team

Bringing specialists together to find the most suitable treatment option for every cancer patient.

Expert Team

Bringing specialists together to find the most suitable treatment option for every cancer patient.
Filter Providers By
Expert Team
Filter Providers By
Close
Search for medical departments based on the first letter of pinyin
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
no data

No relevant content available

Explanatory text explanatory text explanatory text

  • 1
  • 2
  • 3
  • 4
  • 5
Filter Providers By
Search for medical departments based on the first letter of pinyin
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • Liu Rong
    Liu Rong
    Specializes in early cancer screening, precision diagnosis, and full-cycle tumor management.Proficient in the application of molecular imaging technologies—such as PET/CT—for tumor diagnosis and treatment efficacy assessment; dedicated to promoting Multidisciplinary Team (MDT) approaches and integrative medicine models to provide patients with personalized, comprehensive treatment services.
    Profile:
    Fosun Cancer Hospital Guangzhou, Liu Rong, Executive Deputy Director of the Cancer Hospital and Director of the PET/CT Center at Foshan Fosun Chancheng Hospital; holds a Master's degree in Medical Imaging and a Master's degree in Psychology from the Chinese Academy of Sciences; formerly Deputy Director of the Imaging Center at Nanfang Hospital; specializes in early cancer screening, precision diagnosis, PET/CT molecular imaging, and cancer MDT (Multidisciplinary Team) care.
  • Pei Jianhao
    Pei Jianhao
    Specializes in minimally invasive thermal ablation and endocrine therapy for thyroid nodules and papillary thyroid microcarcinoma, as well as multidisciplinary treatment for diabetic foot and the diagnosis and treatment of adrenal tumors.
    Profile:
    Fosun Cancer Hospital Guangzhou, Pei Jianhao, Chief Physician of Oncology Ward 5 at Guangzhou Fosun Chancheng Hospital. He specializes in the clinical diagnosis and treatment of endocrine diseases, with extensive experience in minimally invasive thermal ablation and endocrine therapy for thyroid nodules and papillary thyroid microcarcinoma. He also treats conditions such as hyperthyroidism and adrenal tumors, emphasizing the integration of minimally invasive techniques with endocrine therapy.
  • Wang Songtao
    Wang Songtao
    Specializes in interventional procedures, targeted tumor therapy, immunotherapy, and particle therapy; possesses extensive experience in minimally invasive interventional treatment for conditions such as intermediate-to-advanced lung cancer, liver cancer, nasopharyngeal carcinoma, bone cancer, colorectal cancer, and thyroid cancer.
    Profile:
    Fosun Cancer Hospital Guangzhou, Wang Songtao, Attending Physician in Oncology Ward 5 at Guangzhou Fosun Chancheng Hospital and core member of the Luo Pengfei & Wang Jian interventional research team. He has long specialized in interventional oncology, focusing on minimally invasive interventional treatments for advanced lung cancer, liver cancer, nasopharyngeal carcinoma, bone cancer, colorectal cancer, and thyroid cancer. He is proficient in techniques such as precision DSA interventional embolization, Iodine-125 seed implantation, Argon-Helium cryoablation, and microwave ablation.
  • Liao Longjun
    Liao Longjun
    Specializes in interventional procedures, targeted tumor therapy, immunotherapy, and particle therapy; proficient in minimally invasive techniques such as DSA-guided interventional embolization, particle implantation, cryoablation, and microwave ablation.
    Profile:
    Fosun Cancer Hospital Guangzhou, Liao Longjun, Attending Physician in Oncology Ward 5 at Guangzhou Fosun Chancheng Hospital. He has extensive experience in clinical oncology and interventional radiology, with particular expertise in interventional procedures, targeted therapy, immunotherapy, and radioactive seed implantation. He is highly skilled in minimally invasive techniques such as DSA-guided precision interventional embolization, Iodine-125 seed implantation, Argon-Helium cryoablation, and microwave ablation.
  • Liu Yongguang
    Liu Yongguang
    Specializes in the treatment of tumors using integrated Traditional Chinese and Western medicine, molecular targeted therapy, and minimally invasive interventional procedures; possesses extensive experience in the comprehensive treatment of liver cancer, lung cancer, breast cancer, lymphoma, and other diseases.
    Profile:
    Fosun Cancer Hospital Guangzhou, Liu Yongguang, Attending Physician, Oncology Department (Ward 5), Guangzhou Fosun Chancheng Hospital; Member of the Chinese Society of Clinical Oncology (CSCO); over 20 years of experience in clinical oncology and research; extensive expertise in integrative Chinese and Western medicine, molecular targeted therapy, and minimally invasive interventional therapy; specializes in comprehensive treatment for liver cancer, lung cancer, breast cancer, lymphoma, and tumors of the digestive and respiratory systems.
no data

No relevant content available

Explanatory text explanatory text explanatory text

  • 1
  • 2
  • 3
  • 4
  • 5

Why Choose Us

  • 26,000+
    Over 26,000 international patient visits from 124 countries and regions.
  • 1,000+
    Over 1,000 cancer patients treated with our sixth-generation CyberKnife.
  • 800+
    Over 800 patients treated with the da Vinci Surgical System since April 2023.
  • 500+
    Personalized treatment plans developed for over 500 patients through China–U.S. MDT consultations.

Why Choose Us

  • 26,000+
    Over 26,000 international patient visits from 124 countries and regions.
  • 1,000+
    Over 1,000 cancer patients treated with our sixth-generation CyberKnife.
  • 800+
    Over 800 patients treated with the da Vinci Surgical System since April 2023.
  • 500+
    Personalized treatment plans developed for over 500 patients through China–U.S. MDT consultations.